Measuring tumor hypoxia with 18F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study

Expression of Hypoxia-Inducible Factor (HIF)-1αand Vascular Endothelial Growth Factor (VEGF)-D As Outcome Predictors in Resected Esophageal Squamous Cell Carcinoma

(2013) Ching Tzao et al.   DISEASE MARKERS

Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer

(2010) Ling Li et al.   Clinical Lung Cancer

Beclin-1 Expression is a Predictor of Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma and Correlated to Hypoxia-Inducible Factor (HIF)-1α Expression

(2009) Yongshun Chen et al.   PATHOLOGY & ONCOLOGY RESEARCH

Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer

(2008) Paul M. Schneider et al.   ANNALS OF SURGERY

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma

(2008) N Tanaka et al.   BRITISH JOURNAL OF CANCER

Imaging of Tumor Hypoxia to Predict Treatment Sensitivity

(2008) H. Minn et al.   CURRENT PHARMACEUTICAL DESIGN